LHALA Gel Mask: Clinical Specifications & Efficacy Data
Technical documentation, patented delivery parameters, and independent clinical trial metrics for dermal barrier recovery and post-procedure integration.
Patent 10-1902272
Temperature-Responsive Delivery
Matrix liquefies exclusively at 36.5°C. Active compounds remain structurally intact until direct epidermal contact, triggering controlled transdermal diffusion. Absorption rate increases by 68% compared to standard cellulose matrices.
Patent 10-1553368
3D Embo Hydrogel Architecture
Engineered surface topography increases dermal contact area by 140%. Micro-embossed structures eliminate air pockets, ensuring 0.1mm adherence tolerance for strict occlusion and prevention of active ingredient evaporation.
Biotechnology
Microbiome Barrier Repair
Formulated with 50,000ppm Centella Asiatica extract and 10,000ppm Ceramide NP. Reestablishes lipid bilayer integrity and accelerates epidermal cellular turnover post-ablative treatments.
Clinical Evaluation Metrics
In-vivo study, N=45 subjects, 4-week observation post-Q-Switched Nd:YAG laser protocol.
+315%
Moisture Retention
Recorded at 1-hour post-application. 94% retention sustained at 24-hour mark.
-87.4%
Erythema Reduction
Reduction in post-procedure skin redness achieved within 20 minutes of occlusive application.
-42.6%
TEWL Decrease
Transepidermal Water Loss reduction measured at day 14, confirming barrier restoration.
-34.2%
Wrinkle Depth
Reduction in periorbital fine lines confirmed via 3D optical profilometry at week 4.
Product Specifications
Classification: Clinical Grade Hydrogel Matrix
Net Weight: 25g per single-use sheet
Packaging: 4 sheets per sealed box
Formulation pH: 5.8 ± 0.5
Active Complex: 8-Weight Hyaluronic Acid
Standardized Application Protocol
1. Execute pH 5.5 standardized cleansing.
2. Apply hydrogel matrix evenly, ensuring micro-embossed side contacts epidermis.
3. Maintain at room temperature (20-22°C) for 20-25 minutes.
4. Remove matrix and apply manual compression for residual essence absorption.
5. Post-procedure: Immediate application. Maintenance: 2x weekly.
Regulatory & Safety Notice: Dermatologist-tested and hypoallergenic. Statistical variance in efficacy may occur based on baseline dermatological conditions and treatment adherence. Designed explicitly for cosmetic barrier repair and not intended to replace pharmaceutical intervention for severe dermatitis. Suspend application and consult a licensed practitioner if adverse inflammatory responses manifest. Conduct localized patch testing prior to application on severely compromised stratum corneum.

Reviews
There are no reviews yet.